Related Experiment Videos
[Fish oils and rheumatoid arthritis]
E Ernst1, G L Nielsen, E B Schmidt
1Klinisk kemisk afdeling, reumatologisk afdeling og medicinsk-haematologisk afdeling, Aalborg Sygehus.
Ugeskrift for Laeger
|June 6, 1994
Summary
Fish oil supplements, rich in omega-3 polyunsaturated fatty acids (n-3 PUFA), offer modest benefits for rheumatoid arthritis patients. Studies show improvements in self-reported symptoms with minimal side effects, warranting further long-term research.
Area of Science:
- Rheumatology and Nutritional Science
- Immunology and Inflammation
Context:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease impacting joints.
- Dietary n-3 PUFA (fish oil) is explored for its anti-inflammatory properties in RA management.
- Evidence suggests a potential role for omega-3 fatty acids in modulating RA pathogenesis.
Purpose:
- To review existing double-blind studies on n-3 PUFA supplementation in active rheumatoid arthritis.
- To assess the efficacy and safety of fish oil for RA patients.
- To identify future research directions for n-3 PUFA in RA treatment.
Summary:
- Ten double-blind studies involving daily n-3 PUFA (fish oil) supplementation (3-6g) in active RA patients were analyzed.
- Results indicate a modest improvement in patient-reported disease parameters.
- No serious side effects were reported, suggesting a favorable safety profile.
Impact:
- Fish oil supplementation shows potential as an adjunctive therapy for rheumatoid arthritis.
- Findings support modest symptom improvement and good tolerance in RA patients.
- Further long-term studies are needed to confirm efficacy, optimal dosage, and combination therapy effects.